Skip to main content
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2000;8(5-6):235–239. doi: 10.1155/S106474490000034X

Prevalence of human papillomavirus, Chlamydia trachomatis, and Neisseria gonorrhoeae in commercial sex workers in Japan.

K Ishi 1, F Suzuki 1, A Saito 1, T Kubota 1
PMCID: PMC1784698  PMID: 11220484

Abstract

OBJECTIVE: We used the hybrid capture assays to investigate the prevalence of human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae among commercial sex workers in Tokyo. METHODS: Five hundred forty-six consecutive commercial sex workers (CSW) who visited an STD clinic for STD checkup in 1998 and 1999 were studied. A control group consisted of 233 consecutive women who visited a general gynecological clinic for annual checkup. A cervical sample was obtained for hybrid capture assays for HPV-A (low-oncogenic-risk types), HPV-B (intermediate- and high-oncogenic-risk types), C. trachomatis, and N. gonorrhoeae. Fisher's exact test was used for statistical analyses. RESULTS: The positive rate for HPV-B among the CSW was 48.4%, significantly higher than the 6.0% among the control subjects. The positive rates for HPV-A, C. trachomatis, and N. gonorrhoeae were also significantly higher among the CSW than among the control subjects. Among the microorganisms tested, the positive rate for HPV-B was the highest in both the STD and control groups. CONCLUSIONS: The high prevalence of HPV, C. trachomatis, and N. gonorrhoeae infection in CSW poses a risk of further transmission of STD to the general public, suggesting the need for further education and screening for CSW and the general public. We found high- and intermediate-oncogenic-type HPV to be the most prevalent infection among both CSW and control subjects. Screening for HPV may be necessary in STD and general clinics to predict the risk of cervical malignancy. Hybrid capture assays, which permit simultaneous detection of HPV and other STD with high sensitivity, may be a useful diagnostic method.

Full Text

The Full Text of this article is available as a PDF (718.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borg A. J., Medley G., Garland S. M. Prevalence of HPV in a Melbourne female STD population: comparison of RNA and DNA probes in detecting HPV by dot blot hybridization. Int J STD AIDS. 1993 May-Jun;4(3):159–164. doi: 10.1177/095646249300400307. [DOI] [PubMed] [Google Scholar]
  2. Figueroa J. P., Ward E., Luthi T. E., Vermund S. H., Brathwaite A. R., Burk R. D. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity. Sex Transm Dis. 1995 Mar-Apr;22(2):114–118. doi: 10.1097/00007435-199503000-00007. [DOI] [PubMed] [Google Scholar]
  3. Girdner J. L., Cullen A. P., Salama T. G., He L., Lorincz A., Quinn T. C. Evaluation of the digene hybrid capture II CT-ID test for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol. 1999 May;37(5):1579–1581. doi: 10.1128/jcm.37.5.1579-1581.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Horn J. E., McQuillan G. M., Shah K. V., Gupta P., Daniel R. W., Ray P. A., Quinn T. C., Hook E. W., 3rd Genital human papillomavirus infections in patients attending an inner-city STD clinic. Sex Transm Dis. 1991 Jul-Sep;18(3):183–187. doi: 10.1097/00007435-199107000-00012. [DOI] [PubMed] [Google Scholar]
  5. Kubota T., Ishi K., Suzuki M., Utsuno S., Igari J. Usefulness of hybrid capture HPV DNA assay as a diagnostic tool for human papillomavirus infection. Kansenshogaku Zasshi. 1998 Nov;72(11):1219–1224. doi: 10.11150/kansenshogakuzasshi1970.72.1219. [DOI] [PubMed] [Google Scholar]
  6. Schachter J., Hook E. W., 3rd, McCormack W. M., Quinn T. C., Chernesky M., Chong S., Girdner J. I., Dixon P. B., DeMeo L., Williams E. Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol. 1999 Nov;37(11):3668–3671. doi: 10.1128/jcm.37.11.3668-3671.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sun X. W., Ferenczy A., Johnson D., Koulos J. P., Lungu O., Richart R. M., Wright T. C., Jr Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol. 1995 Nov;173(5):1432–1437. doi: 10.1016/0002-9378(95)90629-0. [DOI] [PubMed] [Google Scholar]
  8. Wallin K. L., Wiklund F., Angström T., Bergman F., Stendahl U., Wadell G., Hallmans G., Dillner J. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med. 1999 Nov 25;341(22):1633–1638. doi: 10.1056/NEJM199911253412201. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES